Proposal for a multidimensional staging system for chronic obstructive pulmonary disease

被引:36
作者
Celli, BR
Calverley, PMA
Rennard, SI
Wouters, EFM
Agusti, A
Anthonisen, N
MacNee, W
Jones, P
Pride, N
Rodriguez-Roisin, R
Rossi, A
Wanner, A
机构
[1] Tufts Univ, St Elizabeths Med Ctr, Dept Pulm & Crit Care Med, Brighton, MA 02135 USA
[2] Univ Liverpool, Fazakerly Hosp, Liverpool, Merseyside, England
[3] Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE USA
[4] Univ Hosp Maastricht, Dept Pulm, Maastricht, Netherlands
[5] Hosp Univ Son Dureta, Palma de Mallorca, Spain
[6] Univ Manitoba, Winnipeg, MB, Canada
[7] ELEGI Med Sch, Edinburgh, Midlothian, Scotland
[8] St Georges Hosp Med Sch, London, England
[9] Natl Heart & Lung Inst, London, England
[10] Univ Barcelona, Hosp Clin, IDIBAPS, Serv Pneumol, Barcelona, Spain
[11] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[12] Univ Miami, Sch Med, Miami, FL USA
关键词
body mass index; chronic obstructive; pulmonary disease; dyspnea; factor analysis; statistical;
D O I
10.1016/j.rmed.2005.03.019
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The severity of chronic obstructive pulmonary disease (COPD) is currently assessed using a single physiological measurement, the forced expiratory volume in 1 s (FEV1). COPD, however, has complex effects on other aspects of respiratory function, and in many patients is associated with important systemic changes. We hypothesized that a multidimensional staging system for COPD could provide a more complete assessment of the disease's impact. We considered over 40 potential staging variables, evaluating them according to sensitivity to change, measured reproducibly, independence of the information they provide and prognostic value. We finally selected three: FEV1 (including arterial blood gas measurements when FEV1 falls below 35% predicted), Medical Research Council dyspnea scale and body mass index (BMI). Each measure correlates independently with prognosis in COPD, is supported by a significant body of literature and serves as a surrogate for other potentially important variables. We then used principal components analysis (PCA) to determine the degree of association between 30 of the potential variables measured in 813 stable COPD patients. Using PCA, six groups of measurements defined independent categories of patient information: pulmonary function (including FEV1), symptoms of cough and sputum, dyspnea, health status, bronchodilator reversibility and BMI. These include the three principal variables selected for the staging system. Although the staging boundaries were based on existing literature, they have proven useful in predicting survival. We conclude that a multidimensional grading system is useful to assess the impact of COPD. (c) 2005 Published by Elsevier Ltd.
引用
收藏
页码:1546 / 1554
页数:9
相关论文
共 36 条
[1]
[Anonymous], 1980, Ann Intern Med, V93, P391
[2]
LUNG-FUNCTION TESTING - SELECTION OF REFERENCE VALUES AND INTERPRETATIVE STRATEGIES [J].
不详 .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05) :1202-1218
[4]
PROGNOSIS IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
WRIGHT, EC ;
HODGKIN, JE ;
HOPEWELL, PC ;
LEVIN, DC ;
STEVENS, PM .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 133 (01) :14-20
[5]
PROGNOSIS IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE - RESULTS FROM MULTICENTER CLINICAL-TRIALS [J].
ANTHONISEN, NR .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (03) :S95-S99
[6]
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease [J].
Bestall, JC ;
Paul, EA ;
Garrod, R ;
Garnham, R ;
Jones, PW ;
Wedzicha, JA .
THORAX, 1999, 54 (07) :581-586
[7]
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].
Burge, PS ;
Calverley, PMA ;
Jones, PW ;
Spencer, S ;
Anderson, JA ;
Maslen, TK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303
[8]
BURROWS B, 1991, EUR RESPIR REV, V1, P340
[9]
2-MINUTE, 6-MINUTE, AND 12-MINUTE WALKING TESTS IN RESPIRATORY-DISEASE [J].
BUTLAND, RJA ;
PANG, J ;
GROSS, ER ;
WOODCOCK, AA ;
GEDDES, DM .
BRITISH MEDICAL JOURNAL, 1982, 284 (6329) :1607-1608
[10]
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].
Celli, BR ;
MacNee, W ;
Agusti, A ;
Anzueto, A ;
Berg, B ;
Buist, AS ;
Calverley, PMA ;
Chavannes, N ;
Dillard, T ;
Fahy, B ;
Fein, A ;
Heffner, J ;
Lareau, S ;
Meek, P ;
Martinez, F ;
McNicholas, W ;
Muris, J ;
Austegard, E ;
Pauwels, R ;
Rennard, S ;
Rossi, A ;
Siafakas, N ;
Tiep, B ;
Vestbo, J ;
Wouters, E ;
ZuWallack, R .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946